Author

J. T. Oliveira

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

C. d. S. G. Pedrosa· 1 shared C. Q. Sacramento· 1 shared C. Verissimo· 1 shared D. Biagi· 1 shared D. R. Furtado· 1 shared E. M. Cruvinel· 1 shared G. Vitoria· 1 shared H. L. Borges· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

C. d. S. G. Pedrosa

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

WIN 55,212-2 shows anti-inflammatory and survival properties in human iPSC-derived cardiomyocytes infected with SARS-CoV-2

L. G. H. S. Aragao, J. T. Oliveira, J. R. Temerozo, M. A. Mendes, J. A. Salerno, C. d. S. G. Pedrosa, T. Puig-Pijuan, C. Verissimo, I. M. Ornelas, T. Torquato, G. Vitoria, C. Q. Sacramento, N. Fintelman-Rodrigues, S. d. S. G. Dias, V. Cardoso Soares, , S. Rehen

This study examines the effects of the cannabinoid agonist WIN 55,212-2 on inflammation and cell survival in human iPSC-derived cardiomyocytes infected with SARS-CoV-2, finding reduced cytokine levels and cytotoxic damage.

bioRxiv · Feb 20, 2021 · PreprintCell Biology